Clinical Trial Update: CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation

View source ↗

Summary

The CLAD study investigating biomarkers to predict rejection and outcomes after lung transplantation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Dysfunction
• Lung Transplant Rejection

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Lung Transplant Failure and Rejection, Primary Graft Dysfunction | Status: TERMINATED